Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear entry of nonviral vectors.

D A Dean1, D D Strong, W E Zimmer

  • 1Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Gene Therapy
|May 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping of host-parasite-microbiome interactions reveals metabolic determinants of tropism and tolerance in Chagas disease.

Science advances·2020
Same author

Identification of an alveolar type I epithelial cell-specific DNA nuclear import sequence for gene delivery.

Gene therapy·2016
Same author

β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.

Gene therapy·2016
Same author

Impacts of spinosad and λ-cyhalothrin on spider communities in cabbage fields in south Texas.

Ecotoxicology (London, England)·2013
Same author

Highly acetylated tubulin permits enhanced interactions with and trafficking of plasmids along microtubules.

Gene therapy·2012
Same author

Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines.

Cancer gene therapy·2012
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Gene delivery faces barriers, especially the nuclear envelope in nondividing cells. This review explores nuclear transport mechanisms for nonviral gene therapy in these cells.

Area of Science:

  • Gene therapy
  • Molecular biology
  • Cellular biology

Background:

  • Nonviral gene delivery is hindered by extracellular and intracellular barriers.
  • The nuclear envelope presents a significant obstacle for gene delivery, particularly in nondividing cells.
  • Efficient gene transfer into nondividing target cells is crucial for effective gene therapy.

Purpose of the Study:

  • To review recent studies on plasmid nuclear import mechanisms in nondividing cells.
  • To discuss strategies for enhancing gene transfer efficiency by overcoming nuclear barriers.
  • To explore the exploitation or circumvention of nuclear transport processes for improved gene therapy outcomes.

Main Methods:

  • Literature review of recent studies on nuclear transport.

Related Experiment Videos

  • Analysis of mechanisms governing plasmid entry into the nucleus of nondividing cells.
  • Synthesis of current approaches to enhance nonviral gene delivery.

    • Main Results:

    • Nuclear import in nondividing cells is a critical bottleneck for nonviral gene delivery.
    • Understanding these transport mechanisms is key to improving transfection efficiency.
    • Various strategies are being developed to facilitate nuclear entry of genetic material.

    Conclusions:

    • Overcoming the nuclear envelope barrier is essential for advancing nonviral gene therapy.
    • Targeting nuclear transport pathways offers promising avenues for therapeutic development.
    • Further research into nuclear import mechanisms will enhance gene transfer efficacy in clinical applications.